Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Stock, par value $0.0001
-
Shares outstanding
-
53M
-
Number of holders
-
87
-
Total 13F shares, excl. options
-
24.6M
-
Shares change
-
-4.04M
-
Total reported value, excl. options
-
$40.4M
-
Value change
-
-$6.88M
-
Put/Call ratio
-
1.34
-
Number of buys
-
43
-
Number of sells
-
-60
-
Price
-
$1.65
Significant Holders of Cardlytics, Inc. - Common Stock, par value $0.0001 (CDLX) as of Q2 2025
132 filings reported holding CDLX - Cardlytics, Inc. - Common Stock, par value $0.0001 as of Q2 2025.
Cardlytics, Inc. - Common Stock, par value $0.0001 (CDLX) has 87 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 24.6M shares
of 53M outstanding shares and own 46.29% of the company stock.
Largest 10 shareholders include CAS Investment Partners, LLC (5.61M shares), VANGUARD GROUP INC (2.42M shares), 683 Capital Management, LLC (1.65M shares), KPS Global Asset Management UK Ltd (1.22M shares), WORLDLY PARTNERS MANAGEMENT, LLC (1.16M shares), MIRABELLA FINANCIAL SERVICES LLP (1.16M shares), BlackRock, Inc. (1.1M shares), LPL Financial LLC (1.05M shares), RBF Capital, LLC (829K shares), and Lane Generational LLC (780K shares).
This table shows the top 87 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.